アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/03/12 | 1,610.5 | 1,610.5 | 1,573 | 1,594.5 | -3.5 | -0.2% | 6,782,500 |
2024/03/11 | 1,577 | 1,603 | 1,573.5 | 1,598 | +22.5 | +1.4% | 10,667,900 |
2024/03/08 | 1,567.5 | 1,581.5 | 1,551 | 1,575.5 | -23.5 | -1.5% | 18,824,400 |
2024/03/07 | 1,624.5 | 1,630.5 | 1,596 | 1,599 | -37.5 | -2.3% | 17,418,900 |
2024/03/06 | 1,636 | 1,650 | 1,626 | 1,636.5 | +0.5 | ±0% | 9,089,400 |
2024/03/05 | 1,662 | 1,670 | 1,635.5 | 1,636 | -45.5 | -2.7% | 11,389,100 |
2024/03/04 | 1,686 | 1,687 | 1,663 | 1,681.5 | +7 | +0.4% | 8,117,400 |
2024/03/01 | 1,656 | 1,679.5 | 1,655 | 1,674.5 | +23 | +1.4% | 7,094,100 |
2024/02/29 | 1,658.5 | 1,666 | 1,638.5 | 1,651.5 | -12.5 | -0.8% | 8,823,500 |
2024/02/28 | 1,665.5 | 1,674.5 | 1,658.5 | 1,664 | +5.5 | +0.3% | 5,539,400 |
2024/02/27 | 1,640 | 1,660 | 1,637 | 1,658.5 | -13 | -0.8% | 10,490,900 |
2024/02/26 | 1,655 | 1,678.5 | 1,649 | 1,671.5 | +22 | +1.3% | 9,134,600 |
2024/02/22 | 1,671 | 1,672.5 | 1,647.5 | 1,649.5 | -27.5 | -1.6% | 11,540,500 |
2024/02/21 | 1,688.5 | 1,691 | 1,675.5 | 1,677 | -8 | -0.5% | 5,663,400 |
2024/02/20 | 1,690 | 1,695.5 | 1,680.5 | 1,685 | +2.5 | +0.1% | 5,214,100 |
2024/02/19 | 1,678.5 | 1,690 | 1,670 | 1,682.5 | +7.5 | +0.4% | 5,396,400 |
2024/02/16 | 1,665 | 1,682 | 1,653 | 1,675 | +22.5 | +1.4% | 7,595,500 |
2024/02/15 | 1,670 | 1,670 | 1,639 | 1,652.5 | -13.5 | -0.8% | 5,805,600 |
2024/02/14 | 1,661.5 | 1,669.5 | 1,646.5 | 1,666 | +11 | +0.7% | 7,484,700 |
2024/02/13 | 1,623 | 1,655 | 1,618 | 1,655 | +39.5 | +2.4% | 10,742,300 |
2024/02/09 | 1,597 | 1,621.5 | 1,594 | 1,615.5 | +5.5 | +0.3% | 9,391,000 |
2024/02/08 | 1,610 | 1,619.5 | 1,591 | 1,610 | -11.5 | -0.7% | 15,869,200 |
2024/02/07 | 1,606 | 1,629 | 1,605 | 1,621.5 | -1.5 | -0.1% | 11,396,000 |
2024/02/06 | 1,662 | 1,699.5 | 1,623 | 1,623 | -77 | -4.5% | 24,370,600 |
2024/02/05 | 1,680 | 1,703 | 1,668 | 1,700 | +20 | +1.2% | 9,320,200 |
2024/02/02 | 1,699.5 | 1,703 | 1,680 | 1,680 | -12 | -0.7% | 7,148,500 |
2024/02/01 | 1,705 | 1,712.5 | 1,680.5 | 1,692 | -33 | -1.9% | 9,933,200 |
2024/01/31 | 1,711 | 1,729.5 | 1,706 | 1,725 | +12 | +0.7% | 6,895,500 |
2024/01/30 | 1,714 | 1,730.5 | 1,713 | 1,713 | +0.5 | ±0% | 4,680,300 |
2024/01/29 | 1,698 | 1,721.5 | 1,698 | 1,712.5 | +24.5 | +1.5% | 6,089,500 |
2024/01/26 | 1,693.5 | 1,695 | 1,676 | 1,688 | -13 | -0.8% | 7,662,700 |
2024/01/25 | 1,700 | 1,707.5 | 1,682.5 | 1,701 | -2 | -0.1% | 8,092,400 |
2024/01/24 | 1,711.5 | 1,718 | 1,702 | 1,703 | -21.5 | -1.2% | 7,092,700 |
2024/01/23 | 1,715 | 1,734 | 1,714 | 1,724.5 | +14.5 | +0.8% | 6,749,400 |
2024/01/22 | 1,705 | 1,716.5 | 1,698 | 1,710 | ±0 | ±0% | 7,908,000 |
2024/01/19 | 1,710.5 | 1,733 | 1,707.5 | 1,710 | -6.5 | -0.4% | 7,385,400 |
2024/01/18 | 1,744 | 1,758 | 1,715.5 | 1,716.5 | -25 | -1.4% | 9,201,600 |
2024/01/17 | 1,790 | 1,801.5 | 1,741.5 | 1,741.5 | -42 | -2.4% | 10,787,100 |
2024/01/16 | 1,760.5 | 1,786.5 | 1,757.5 | 1,783.5 | +26 | +1.5% | 6,392,700 |
2024/01/15 | 1,755.5 | 1,763 | 1,749 | 1,757.5 | +3.5 | +0.2% | 4,896,900 |
2024/01/12 | 1,800 | 1,800 | 1,747.5 | 1,754 | -10 | -0.6% | 9,901,600 |
2024/01/11 | 1,782 | 1,785 | 1,756 | 1,764 | +1 | +0.1% | 9,077,200 |
2024/01/10 | 1,744 | 1,770.5 | 1,743 | 1,763 | +24.5 | +1.4% | 8,374,600 |
2024/01/09 | 1,726 | 1,756 | 1,721.5 | 1,738.5 | -27.5 | -1.6% | 8,674,400 |
2024/01/05 | 1,762.5 | 1,784.5 | 1,757.5 | 1,766 | +17 | +1% | 8,687,700 |
2024/01/04 | 1,716.5 | 1,749 | 1,701.5 | 1,749 | +63 | +3.7% | 8,582,600 |
2023/12/29 | 1,681.5 | 1,690 | 1,675.5 | 1,686 | +1.5 | +0.1% | 5,307,500 |
2023/12/28 | 1,679 | 1,689.5 | 1,670.5 | 1,684.5 | +7 | +0.4% | 4,803,700 |
2023/12/27 | 1,660 | 1,682 | 1,658 | 1,677.5 | +10 | +0.6% | 6,046,300 |
2023/12/26 | 1,674.5 | 1,679 | 1,659.5 | 1,667.5 | -4 | -0.2% | 3,990,600 |
351~
400
件表示中 / 3763件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 167,100円 | +0.9% | +380.2% | 4.67% | 23.02倍 | 1.98倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
第一三共 | 367,600円 | +6.0% | +4.0% | 2.12% | 22.68倍 | 4.19倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 789,000円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 262,600円 | +20.9% | +10.6% | 2.51% | 12.42倍 | 1.64倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 263,300円 | -3.5% | -11.3% | 2.28% | 24.18倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム